Integrated public single cell re-analysis reveals rare intermediate cell type in neurodegenerative disease

KEYWORDS: scRNA-Seq & bulk RNA-seq | Therapeutic targets discovery | Public datasets | Neurodegenerative disorder | Oligodendrocytes


BISC’s customer is involved in remyelination research. Remyelination is a key process to heal the brain after traumatic or disease-related injury. Uncovering driver mechanisms could result in therapeutic targets for chronic neurodegenerative disease where remyelination fails.


Integration of multiple public single-cell RNA repositories, combined with extensive downstream analysis, trajectory analysis and regulatory network inference. 


  • Clarification of differentiation process beyond the state-of-the-art
  • Creation of a unique data repository to mine for novel markers
  • Confirmation and discovery of new therapeutic targets

Check our other Resources on Single Cell & Transcriptomics:

Contact us to discuss your project

    I agree to the privacy policy